Greenwich LifeSciences, Inc. is a clinical stage biopharmaceutical company developing novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Known as Norwell, Inc. until 2018, Greenwich LifeSciences was incorporated in 2006 and is headquartered in Stafford, TX.
Name / Ticker | Price | Zen Rating |
---|---|---|
$14.05 | A | |
$7.70 | A | |
$34.22 | A |